Myphetane Dc

   
Google
 
Web NewDrugInformation.com

Myphetane Dc


Drug - Myphetane Dc
The trade name of the product as shown on the labeling.

Dosage - SYRUP; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Brompheniramine Maleate; Codeine Phosphate; Phenylpropanolamine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 2MG/5ML;10MG/5ML;12.5MG/5ML
The potency of the active ingredient(s), Brompheniramine Maleate; Codeine Phosphate; Phenylpropanolamine Hydrochloride. May repeat for multiple part products.

Applicant - MORTON GROVE
The firm name holding legal responsibility for Myphetane Dc. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088904
The FDA assigned number to Myphetane Dc. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Myphetane Dc. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Feb 21, 1985
The date Myphetane Dc was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Myphetane Dc. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Myphetane Dc is in. Format is RX, OTC, DISCN.

Applicant Full Name - Morton Grove Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Myphetane Dc.

Myphetane Dc